Georgina Venetia Long (born 15 November 1970) is an Australian medical oncologist, clinical trialist and translational researcher, and works in drug therapy development.
Long was the first woman and first Australian to be named president of the US-based Society for Melanoma Research.
[4] Long began studying a combined degree of science and law at the University of Sydney, but gave up law and graduated with a double major in pure maths and chemistry in 1993, before completing a PhD in organic chemistry, also at Sydney University, in 1996.
She has led numerous clinical trials,[7] focusing on targeted therapies and immuno-oncology in melanoma.
Together they have been part of a team pioneering the use of immunotherapy treatment for melanoma, which Long then adapted for brain cancer when Scolyer was diagnosed with it in June 2023.